Approvals/NMPA/Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (I)

Approved

化学药品

Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (I)

ASTRAZENECA AB🇨🇳 National Medical Products Administration

Approval Id: 8E25D1MYokB
Approval Number: 国药准字HJ20171049
Generic Name: 沙格列汀二甲双胍缓释片(Ⅰ)
Generic Name En: Saxagliptin and Metformin Hydrochloride Sustained-release Tablets (I)
Trade Name: 安立格
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含沙格列汀5mg和盐酸二甲双胍1000mg
Reg Date: 2021-10-26
Expired Date: 2026-10-25
Company Name: ASTRAZENECA AB
Production Company Name: ASTRAZENECA PHARMACEUTICALS LP
Company Detail Path: /organization/astrazeneca-ab
Production Company Detail Path: /organization/astrazeneca-pharmaceuticals-lp

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Oct 26, 2021

Approval ID

8E25D1MYokB

Type

化学药品